Favorable Outcome of Severe Acute Hepatitis B in a Patient Treated with Antithrombin III and Antiviral Therapy

Abstract

There is our observation regarding the combination of antiviral agents and antithrombin III concentrate that could be beneficial in the fulminant course of SAHB in the future.

Keywords

• lamivudine
• severe acute hepatitis B
• antithrombin III
• venous thromboembolism
• methylenetetrahydrofolate reductase
• fulminant course